Sodium -glucose contransporter 2 inhibitor derivative

Abstract

In some embodiments of the present disclosure, a sodium-glucose cotransporter 2 (SGLT2) inhibitor derivative is provided, comprising a backbone structure and a hydrophobic functional group, in which the backbone structure comprises a glucoside or a glucoside analog, in which the glucoside or the glucoside analog is bonded to the hydrophobic functional group via a covalent bond.

Dependencies are inferred from the claim text.